Menu

Bristol Myers Squibb said its 340B contract pharmacy restrictions and in-house pharmacy claims data requirements no longer apply to Washington state covered entities.

BMS Exempts WA From In-House Claims Data Reqs, CP Restrictions

June 30, 2026 Shannon Young, Managing Editor 340B Report Views

A New Jersey-based drugmaker recently announced that its 340B contract pharmacy restrictions and in-house pharmacy claims data requirements no longer [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

340B Research Roundup: Health Affairs Scholar Study, ADAP White Paper, Op-Eds

Fed. Judge Lets Most State Claims Proceed in 340B Insulin Antitrust Suit